Nadine Krüger

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell · 2020 · 21.4K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · Cell · 2021 · 1K citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Markus Hoffmann, Nadine Krüger, Sebastian Schulz et al. · Cell · 2021 · 955 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Markus Hoffmann, Hannah Kleine‐Weber, Nadine Krüger et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 757 citations · Full text

Life Sciences, Biomedical Sciences, Infectious Diseases +15

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Markus Hoffmann, Kirstin Mösbauer, Heike Hofmann-Winkler et al. · Nature · 2020 · 509 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10